Deprecated: Required parameter $cat_id follows optional parameter $type in /www/wwwroot/ebimall.com/systems/hong.php on line 2088

Deprecated: Required parameter $where follows optional parameter $tree_id in /www/wwwroot/ebimall.com/systems/hlb.php on line 3505
Xcessbio/Cyclopamine, Hedgehog Antagonist-Xcessbio Biosciences Inc/10 mM in DMSO (0.487 mL)/M60022-2188bio精品生物—专注于实验室精品爆款的电商平台 - 蚂蚁淘旗下精选188款生物医学科研用品
您好,欢迎您进入188进口试剂采购网网站! 服务热线:4000-520-616
蚂蚁淘商城 | 现货促销 | 科研狗 | 生物在线
产品资料

Xcessbio/Cyclopamine, Hedgehog Antagonist-Xcessbio Biosciences Inc/10 mM in DMSO (0.487 mL)/M60022-2

Details
Product Information
Chemical Name:(2'R,3S,3'R,3a'S,6aS,6bS,6'S,7a'R,11aS,11bR)-3',6',10,11b-tetramethyl-1,2,3,3a',4,4',5',6,6a,6b,6',7,7',7a',8,11,11a,11b-octadecahydro-3'H-spiro[benzo[a]fluorene-9,2'-furo[3,2-b]pyridin]-3-ol
Molecular Weight:411.62
Formula:C27H41NO
Purity:≥98%
CAS#:4449-51-8
Solubility:DMSO up to 20 mM
Storage:Powder:4oC 1 year DMSO:4oC3 month-20oC 1 year

Biological Activity:

Cyclopamine is a potent and selective inhibitor of the hedgehog signaling with an IC50 ~46 nM, acting as an antagonist of Smoothened. It is a natural product isolated from the corn lily (Veratrum californicum). As the hedgehog signaling pathway plays very important roles in embryogenesis and cancer progression, Cyclopamine has been used in stem cell differentiation, such as pancreatic cell differentiation from ESC/iPSC, or treating Hh pathway dependent cancer in vitro and in vivo.

How to Use:

  • In vitro: Cyclopamine was used at 3 µM in vitro and in cellular assays.
  • In vivo: Cycloppamine was administered at 50 mg/kg by subcutaneous injection once per day in tumor xenograft mouse model.

Reference:

  1. 1. Chen JK, et al. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. (2002) Genes Dev. 16(21):2743-8.
  2. 2. Scott MP. Cancer: a twist in a hedgehog's tale. (2003) Nature. 425(6960):780-2.
  3. 3. D'Amour KA, et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. (2006) Nat Biotechnol. 24(11):1392-401.
  4. 4. Bar EE, et al. Cyclopamine-mediated hedgehog pathway inhibition depletes stem-like cancer cells in glioblastoma. (2007) Stem Cells. 25(10):2524-33.
  5. 5. Jiang J, et al. Hedgehog signaling in development and cancer. (2008) Dev Cell. 15(6):801-12.
  • Product Specification:
  • cyclopamine_spec.pdf
  • Product MSDS:
  • cyclopamine_MSDS.pdf

Products are for research use only. Not for human use.

新闻动态
行业前沿
技术文章
最新产品